MBS8400261 | Anti-CD22 (Inotuzumab Ozogamicin); Humanized Antibody

Anti-CD22 (Inotuzumab Ozogamicin); Humanized Antibody | MBS8400261 | Mybiosource

Product Short Name: [CD22]

Product Name Synonyme: [CMC 544; CMC-544; CMC544; PF-05208773; WAY-207294; Way 207294; SIGLEC2; SIGLEC-2]

Other Names: N/A

Product Gene Name: [CD22]

Product Gene Name Synonyme: N/A

Other Gene Names: N/A

Clonality: Monoclonal

Isotype: IgG4; kappa

Clone: N/A

Host: Human

Reactivity: Human

Specificity: The biosimilar is an antibody-drug conjugate that targets CD22 that is highly expressed on the B cell surface. Upon detachment from the antibody inside the cell; the drug causes double-stranded DNA breaks; which leads to cell cycle arrest; and apoptosis of tumor cells

Purity: Protein A purified

Form: Colorless liquid. In PBS; pH7.5

Concentration: 1mg/ml

Storage Stability: Store at -80 degree C. The antibody solution should be gently mixed before use.
Shipping: Gel Pack
Shelf Life: Est.~12 months
Country of Origin: USA

Tested Application: N/A